{
    "paper_id": "PMC5075008",
    "metadata": {
        "title": "Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis",
        "authors": [
            {
                "first": "Debajit",
                "middle": [],
                "last": "Dey",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Manidipa",
                "middle": [],
                "last": "Banerjee",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Life cycles of the known hepatotropic viruses \u2013 particularly A, B, C and E \u2013 have been studied in significant detail. Although the lack of appropriate cell culture systems, and the slow-growing nature of the virus, has hampered studies, considerable information is available on the entry, replication and exit mechanisms of these viruses, and on specific host-interacting partners for each virus. Hepatitis A virus (HAV) is thought to associate with a cell-surface protein receptor, HAVcr-1/TIM-1 (Hepatitis A virus cellular receptor 1/T-cell immunoglobulin and mucin domain 1), a member of the immunoglobulin superfamily, by which it gains entry into host cells.5 Post-entry, translation of the positive-sense RNA genome by the host ribosomal machinery, mediated via the presence of an internal ribosome entry site (IRES) encoded in the 5\u2019-untranslated region (UTR) of viral RNA, results in the production of a large viral polyprotein. The polyprotein is cleaved into structural (VP1-2A, VP2, VP3, VP4) and non-structural proteins (2B, 2C, 3A, 3B, 3C, 3D) as well as intermediates (3CD, 2BC etc) by a virally-encoded protease 3Cpro. Following the cleavage event, the viral RNA replicase synthesizes a minus-sense strand corresponding to the viral RNA genome, which serves as a template for the production of multiple plus-sense strands. Meanwhile, structural proteins assemble to form virions, which package a majority of the plus-sense RNA generated during replication. Two specific cleavage events result in generation of mature infectious virions - the VP1-2A precursor cleavage and the VP4/VP2 junctional cleavage.6\u201311 Virions are subsequently released from the apical membrane of infected hepatocytes.11",
            "cite_spans": [
                {
                    "start": 663,
                    "end": 664,
                    "mention": "5",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 1619,
                    "end": 1620,
                    "mention": "6",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 1621,
                    "end": 1623,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1707,
                    "end": 1709,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Life cycle of hepatotropic viruses ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Entry of hepatitis C virus (HCV) into target host cells is a multistep event, requiring several host components. The cellular receptors and surface molecules, which are thought to be involved in this process, include the C-type lectins liver/lymph node-specific ICAM-3-grabbing integrin (L-SIGN) and dendritic cell (DC)-specific intercellular adhesion molecule-3 (ICAM-3)-grabbing nonintegrin (DC-SIGN), glycosaminoglycans (GAGs), claudins 6 and 9 and CD-81.12\u201314 Binding to cellular receptor(s) is primarily mediated by the viral envelope proteins E1 and E2. Post-entry, the virus nucleocapsid disassembles releasing the plus-sense RNA genome in the cell cytosol, which acts as a template for 5\u2019-IRES mediated translation. The single HCV polyprotein generated during translation, like the corresponding HAV polypeptide, also undergoes protease mediated co- and post-processing to yield the entire repertoire of viral structural and non-structural proteins.14 During HCV infection, membranous webs14\u201316 are formed, which are sites for RNA replication (NS5B mediated) and translational post-processing events. While the endoplasmic reticulum (ER) serves as the site for the formation of the viral nucleocapsid, envelope formation and final virus maturation occurs in the Golgi. Matured virions are exocytosed into the extracellular space.14",
            "cite_spans": [
                {
                    "start": 458,
                    "end": 460,
                    "mention": "12",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 461,
                    "end": 463,
                    "mention": "14",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 957,
                    "end": 959,
                    "mention": "14",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 997,
                    "end": 999,
                    "mention": "14",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 1000,
                    "end": 1002,
                    "mention": "16",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 1337,
                    "end": 1339,
                    "mention": "14",
                    "ref_id": "BIBREF24"
                }
            ],
            "section": "Life cycle of hepatotropic viruses ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "The life cycle of hepatitis E virus (HEV) is not well understood, primarily due to the non-availability of an appropriate cell culture system. Studies have shown the possible involvement of heat shock cognate 70 protein (HSC70) and heparan sulfate proteoglycans (HSPGs) in the initial attachment of HEV to its target cells, while the final entry is mediated by a yet unknown receptor.17,18 Several host factors, such as glucose-regulated protein 78 (Grp78) and heat shock protein 90 (HSP90), are also thought to be involved in viral entry.19,20 Capsid uncoating and RNA genome release in the cytosol is closely followed by translation of the viral open reading frame (ORF) 1, which encodes the entire non-structural cassette.21,22 Multiple copy synthesis of the positive-sense RNA genome is mediated by virus-encoded RNA-dependent RNA polymerase via a negative-sense RNA intermediate. The viral ORF2 encodes the capsid protein, which associates with the progeny viral genomes to form the nucleocapsids, followed by the intracellular transport and release of mature virions.21,22 It has been postulated that the viral ORF3 encodes a protein involved in intracellular trafficking process.21,22",
            "cite_spans": [
                {
                    "start": 384,
                    "end": 386,
                    "mention": "17",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 387,
                    "end": 389,
                    "mention": "18",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 539,
                    "end": 541,
                    "mention": "19",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 542,
                    "end": 544,
                    "mention": "20",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 725,
                    "end": 727,
                    "mention": "21",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 728,
                    "end": 730,
                    "mention": "22",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 1073,
                    "end": 1075,
                    "mention": "21",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 1076,
                    "end": 1078,
                    "mention": "22",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 1186,
                    "end": 1188,
                    "mention": "21",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 1189,
                    "end": 1191,
                    "mention": "22",
                    "ref_id": "BIBREF33"
                }
            ],
            "section": "Life cycle of hepatotropic viruses ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "HBV, unlike other hepatotropic viruses, has a distinct mechanism for propagation within its host. Cellular entry of incoming particles via endocytosis is initiated through interactions with HSPGs,23,24 followed by that with the sodium taurocholate cotransporting polypeptide (NTCP).24,25 After gaining access to the cytosol, the virus travels to the nuclear pore complex, where the DNA genome is released into the nucleus. The partially double-stranded DNA genome is subsequently converted into a covalently closed circular DNA (cccDNA) form which associates with histones and other nuclear proteins. Within the nucleus, transcription events lead to the production of mRNA, encoding for the reverse transcriptase and the nucleocapsid (pregenomic). In addition, transcripts encoding the surface antigens (subgenomic) are also produced. Both pre- and subgenomic transcrpits are transferred to the cytosol. Surface protein synthesis, to generate core and subviral particles, occurs in the ER. Translation products (viral polymerase and core protein) of the pregenomic RNA associate with protein kinases (PKs),26,27 HSPs27,28 and pregenomic RNA to yield mature core particles, which are either released from infected cells, or are recirculated to the nucleus to maintain the cccDNA level.25,28 Interestingly, while subviral particles are released via the secretory pathway involving the Golgi and ER, mature core particles are released through multivesicular particles.25",
            "cite_spans": [
                {
                    "start": 196,
                    "end": 198,
                    "mention": "23",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 199,
                    "end": 201,
                    "mention": "24",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 282,
                    "end": 284,
                    "mention": "24",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 285,
                    "end": 287,
                    "mention": "25",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 1106,
                    "end": 1108,
                    "mention": "26",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 1109,
                    "end": 1111,
                    "mention": "27",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 1116,
                    "end": 1118,
                    "mention": "27",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 1119,
                    "end": 1121,
                    "mention": "28",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 1284,
                    "end": 1286,
                    "mention": "25",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 1287,
                    "end": 1289,
                    "mention": "28",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 1465,
                    "end": 1467,
                    "mention": "25",
                    "ref_id": "BIBREF36"
                }
            ],
            "section": "Life cycle of hepatotropic viruses ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Although not much is known regarding the cellular entry process of hepatitis D virus (HDV), studies have suggested similarities with the HBV entry pathway involving interaction of HSPGs and NTCPs with the viral large hepatitis B surface antigen (L-HBsAg; pre-S1 domain).24,29 Post-entry, transfer of the RNA genome to the nucleus is facilitated by the virally-encoded hepatitis D antigen (HDAg).30 Within the nucleus, host RNA polymerases initiate genome replication, which proceeds via a rolling circle mechanism.30 Subsequent transcriptional and translational events lead to the production of the large delta antigen which undergoes prenylation prior to association with progeny viral genomes. Subsequent assembly and viral release requires assistance from HBV.30",
            "cite_spans": [
                {
                    "start": 270,
                    "end": 272,
                    "mention": "24",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 273,
                    "end": 275,
                    "mention": "29",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 395,
                    "end": 397,
                    "mention": "30",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 514,
                    "end": 516,
                    "mention": "30",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 763,
                    "end": 765,
                    "mention": "30",
                    "ref_id": "BIBREF42"
                }
            ],
            "section": "Life cycle of hepatotropic viruses ::: Introduction",
            "ref_spans": []
        },
        {
            "text": "Currently there are no specific treatment options available for HAV. Infected individuals usually receive symptomatic treatment, with liver transplantation being the only viable option in cases of FHF.11 Vaccination, with inactivated HAV virions, is fairly effective for conferring protection against all prevalent strains of the virus found in the human population.31,32 Vaccination with attenuated virions has also been employed, but has met with limited success.33 In spite of active vaccination efforts, however, the number of clinical cases of HAV reported is quite high, being \u223c1.5 million worldwide.11",
            "cite_spans": [
                {
                    "start": 201,
                    "end": 203,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 366,
                    "end": 368,
                    "mention": "31",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 369,
                    "end": 371,
                    "mention": "32",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 465,
                    "end": 467,
                    "mention": "33",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 606,
                    "end": 608,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "HAV :::  ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Due to the mostly asymptomatic nature of acute HCV infection, treatment options are limited. However, studies have reported that interferon-based treatment at an early stage might be helpful.34 Individuals exhibiting HCV RNA and antibodies at detectable levels in their blood after more than 6 months post-infection are considered to be cases of chronic HCV infection. A combination therapy of ribavirin and Peg-IFN-\u03b1 (pegylated interferon \u03b1), for a duration of either six months or one year, was the accepted treatment regimen for chronic cases of HCV infection up until 2011.35 However, achievement of a sustained virological response (SVR), which is the key to cure, was observed to vary between genotypes and populations.36 Western European patients infected with HCV genotype 1 reportedly achieve a higher SVR (50%) than the North American patient population (40%). The SVR achieved with this treatment in case of patients infected with genotypes 2, 3, 5 and 6 was observed to be higher in general compared to genotype 1-infected patients (SVR of up to 80%). In particular, genotype 2 was the found to be most susceptible (SVR > 80%).36 Direct-acting antivirals (DAAs) such as telaprevir and boceprevir (first-wave, first generation), which target the HCV NS3-4A serine protease, were introduced in 2011 for treating infections caused by HCV genotype 1.37 Phase III clinical trials on treatment-na\u00efve patients found that administration of telaprevir and boceprevir in conjunction with ribavirin and Peg-IFN-\u03b1 (triple-combination) was effective in achieving a SVR in the range between 65% and 75%.37 However, this treatment regimen comes with its own set of disadvantages, including significant side-effects and not being cost-effective in the case of patients with advanced fibrosis.37 Since 2011, the following DAAs have been approved which can be used either independently or in combination with Peg-IFN-\u03b1 and/or ribavirin. These DAAs are (a) sofosbuvir (nucleotide analogue), (b) simeprevir (NS3-4A protease inhibitor), (c) daclatasvir (NS3-4A protease inhibitor), (d) paritaprevir (NS3-4A protease inhibitor), (e) ombitasvir (NS5A inhibitor), (f) asunaprevir (NS3-4A protease inhibitor), (g) grazoprevir (NS3-4A protease inhibitor) and (h) elbasvir (NS5A replication complex inhibitor).35 The rate of SVR achieved depends on the combination used, the genotype, the presence of resistant strains and the disease severity. Finally, attempts to create an effective vaccine against HCV have not been successful till date due to the extreme sequence variation of the virus genome.",
            "cite_spans": [
                {
                    "start": 191,
                    "end": 193,
                    "mention": "34",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 577,
                    "end": 579,
                    "mention": "35",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 725,
                    "end": 727,
                    "mention": "36",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 1139,
                    "end": 1141,
                    "mention": "36",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 1358,
                    "end": 1360,
                    "mention": "37",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 1601,
                    "end": 1603,
                    "mention": "37",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 1788,
                    "end": 1790,
                    "mention": "37",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 2295,
                    "end": 2297,
                    "mention": "35",
                    "ref_id": "BIBREF47"
                }
            ],
            "section": "HCV :::  ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Acute HEV infections in immunocompetent individuals usually culminate in spontaneous clearance of the virus after a certain time period. However, in severe cases leading to decreased liver functioning, administration of ribavirin was found to help in prompt clearance of the virus and inhibition of further liver damage.38 It remains unclear if ribavirin intake can arrest the progress towards complete liver failure (fulminant hepatitis). Till date, liver transplantation from appropriate donors remains the only choice for such patients.39 For treatment of transplantation patients suffering from chronic infection with HEV, the following course of action is usually undertaken post-transplantation. The first step involves the reduction of immunosuppression, which has been shown to have a 25% clearance rate.40 If this is unsuccessful, the next step usually involves monotherapy with ribavirin for an initial period of 90 days.39,41,42 Administration of Peg-IFN-\u03b1 is also an option; however, due to its many side-effects and complications in solid organ transplantation recipient patients, it is not preferred.39 HEV infection in pregnant women is associated with significant complications like stillbirths, abortions, premature distribution and maternal or fetal death.43 Interestingly, significant differences exist in the severity of complications caused by HEV infection in diverse endemic populations. For instance, while the infection typically has severe outcomes in pregnant women from northern India, it follows a fairly benign course in populations from Egypt and western countries.44,45 Studies suggest that poor prenatal care and nutrition may constitute major contributory factors for such severe outcomes in selected populations.46 Efforts are ongoing to develop an effective vaccine against HEV, and currently a promising candidate (trade name: Hecolin) is in Phase IV of clinical trials (clinicaltrials.gov database).",
            "cite_spans": [
                {
                    "start": 320,
                    "end": 322,
                    "mention": "38",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 539,
                    "end": 541,
                    "mention": "39",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 812,
                    "end": 814,
                    "mention": "40",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 931,
                    "end": 933,
                    "mention": "39",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 934,
                    "end": 936,
                    "mention": "41",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 937,
                    "end": 939,
                    "mention": "42",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 1114,
                    "end": 1116,
                    "mention": "39",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 1274,
                    "end": 1276,
                    "mention": "43",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 1596,
                    "end": 1598,
                    "mention": "44",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 1599,
                    "end": 1601,
                    "mention": "45",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 1747,
                    "end": 1749,
                    "mention": "46",
                    "ref_id": "BIBREF59"
                }
            ],
            "section": "HEV :::  ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "As with other forms of hepatitis, acute infections with HBV are treated symptomatically47,48 and no specific treatment regimen exists. However, patients who develop acute liver failure resulting from severe HBV infection are administered oral anti-HBV medication.49 The major emphasis so far is on treatment of chronic infection of HBV. The currently approved drugs are interferons, Peg-IFN-2a for adults and IFN-\u03b1-2b for children, and nucleotide/nucleoside analogues or NAs (nucleoside analogues: lamivudine, entecavir, emtricitabine, telbivudine; nucleotide analogues: adefovir, tenofovir).50,51 Due to their high barrier to development of resistance, tenofovir and entecavir are used as the first-line drugs for treatment.50,51 Other analogues like lamivudine, adefovir and telbivudine are only prescribed when the more potent drugs are either not appropriate or not available.50,51 This is due to fact that these drugs either have a low barrier to resistance (telbivudine), are less efficacious (adefovir) or have been shown to develop resistance over long-term usage (lamivudine).50 Interferons are utilized as they enhance the host antviral immune response.50,51 The therapeutic strategy usually involves two specific routes applicable to chronic hepatitis B (CHB): (i) a short treatment (1 year) with Peg-IFNs or NAs and (ii) treatment with NAs on a long-term basis.",
            "cite_spans": [
                {
                    "start": 87,
                    "end": 89,
                    "mention": "47",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 90,
                    "end": 92,
                    "mention": "48",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 263,
                    "end": 265,
                    "mention": "49",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 592,
                    "end": 594,
                    "mention": "50",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 595,
                    "end": 597,
                    "mention": "51",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 725,
                    "end": 727,
                    "mention": "50",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 728,
                    "end": 730,
                    "mention": "51",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 880,
                    "end": 882,
                    "mention": "50",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 883,
                    "end": 885,
                    "mention": "51",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 1085,
                    "end": 1087,
                    "mention": "50",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 1163,
                    "end": 1165,
                    "mention": "50",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 1166,
                    "end": 1168,
                    "mention": "51",
                    "ref_id": "BIBREF65"
                }
            ],
            "section": "HBV :::  ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Patients undergoing liver transplantation due to HBV-related HCC or decompensated liver cirrhosis undergo a pre-transplantation treatment regime with a potent NA having a high resistance barrier in order to reduce the viral DNA levels to a minimum before transplantation.58,59 Post-treatment, a combination of adefovir and/or lamivudine with hepatitis B immunoglobulin (HBIg) has been found to be effective (graft rejection rate of less than 10%).59,60 Given the treatment scenario and the complications associated, prevention of HBV infections is a priority. An effective vaccine against HBV exists and is administered 3\u20134 times over a 6 month period.58",
            "cite_spans": [
                {
                    "start": 271,
                    "end": 273,
                    "mention": "58",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 274,
                    "end": 276,
                    "mention": "59",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 447,
                    "end": 449,
                    "mention": "59",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 450,
                    "end": 452,
                    "mention": "60",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 652,
                    "end": 654,
                    "mention": "58",
                    "ref_id": "BIBREF72"
                }
            ],
            "section": "HBV :::  ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Till date, there are no known effective therapeutic strategies available for treatment of either the acute or chronic forms of HDV infection.61 Studies have shown that long-term treatment with Peg-IFN\u03b1 helps in clearance of the virus in about 25% of the cases.61 The efficacy is similar when interferon is administered in combination with adefovir.61 Thus, in the absence of an effective antiviral therapy, liver transplantation is the only option for patients suffering from liver damage due to chronic infection. There are no commercially available vaccines against HDV; however, the vaccine available for HBV can be used to prevent co-infection of HBV and HDV.61",
            "cite_spans": [
                {
                    "start": 141,
                    "end": 143,
                    "mention": "61",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 260,
                    "end": 262,
                    "mention": "61",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 348,
                    "end": 350,
                    "mention": "61",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 663,
                    "end": 665,
                    "mention": "61",
                    "ref_id": "BIBREF76"
                }
            ],
            "section": "HDV :::  ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Based on the current knowledge of the molecular details of viral life cycles and virus-host interactions, there can be several targets for designing inhibitors. The following classes of inhibitors are discussed below: (i) viral polymerase inhibitors, (ii) viral protease inhibitors, (iii) CyPA inhibitors and (iv) host lipid modulators.",
            "cite_spans": [],
            "section": "Viral inhibitors and their mechanism of action ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Several new targets have been identified in HBV against which inhibitors have been designed, and many are presently at different stages of development or in clinical trials. These include potent polymerase inhibitors, entry inhibitors, cccDNA inhibitors, nucleocapsid assembly inhibitors, inhibitors of viral gene expression and HBsAg release inhibitors. Equally effective but safer derivatives of tenofovir and entecavir (tenofovir alafenamide and besofovir) have shown promising results in randomized phase III trials with respect to bone and renal safety profiles.74\u201377 Besofovir is another drug which is being tested as an alternative to entecavir.78,79 Myrcludex-B is an engineered lipopeptide that effectively blocks NTCP receptors, the entry points for incoming HBV virions.80 Mouse model studies with Myrcludex-B have shown a reduction in both cccDNA levels and virus spread, and phase II clinical trials are currently ongoing.80 Three types of site-specific DNA binding proteins are being engineered to target cccDNA: zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regulatory interspaced short palindromic repeats (CRISPR)-Cas endonucleases.81\nIn vitro studies in cells have shown that all three systems can deactivate cccDNA by either site-specific cleavage,82 by introducing frameshifts in viral ORFs83 or by specific disruption (CRISPR-Cas).84,85 Disubstituted sulphonamides (CCC-0975 and CCC-0346) have also been identified; these have been shown to prevent the formation of cccDNA from relaxed circular DNA in vitro.86 Compounds that prevent the encapsidation of viral pregenomic RNA, such as sulfamoylbenzamide and phenylpropenamide derivatives, also constitute attractive options for therapy.87,88 These are effective against both NA-resistant and wild-type HBV.89 Inhibition of viral gene expression using RNA interference (RNAi) is a very attractive option since low levels of viral antigens will allow the immune system to recover. ARC-520, one such drug under development, has shown promising results in vitro.90,91 A nucleic acid polymer, REP 2055, has been shown to be able to inhibit the release of HBsAg from infected hepatocytes in in vivo studies.92 Finally, recent studies have also shown that the HBV RnaseH, which is critical for virus replication, can also be an important drug target.93,94 As in the case of HBV, novel drug targets have been identified in other hepatotropic viruses as well (Table 1).",
            "cite_spans": [
                {
                    "start": 567,
                    "end": 569,
                    "mention": "74",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 570,
                    "end": 572,
                    "mention": "77",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 652,
                    "end": 654,
                    "mention": "78",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 655,
                    "end": 657,
                    "mention": "79",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 781,
                    "end": 783,
                    "mention": "80",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 935,
                    "end": 937,
                    "mention": "80",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 1204,
                    "end": 1206,
                    "mention": "81",
                    "ref_id": "BIBREF98"
                },
                {
                    "start": 1322,
                    "end": 1324,
                    "mention": "82",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 1365,
                    "end": 1367,
                    "mention": "83",
                    "ref_id": "BIBREF100"
                },
                {
                    "start": 1407,
                    "end": 1409,
                    "mention": "84",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 1410,
                    "end": 1412,
                    "mention": "85",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 1584,
                    "end": 1586,
                    "mention": "86",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 1762,
                    "end": 1764,
                    "mention": "87",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 1765,
                    "end": 1767,
                    "mention": "88",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 1832,
                    "end": 1834,
                    "mention": "89",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 2084,
                    "end": 2086,
                    "mention": "90",
                    "ref_id": "BIBREF108"
                },
                {
                    "start": 2087,
                    "end": 2089,
                    "mention": "91",
                    "ref_id": "BIBREF109"
                },
                {
                    "start": 2227,
                    "end": 2229,
                    "mention": "92",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 2369,
                    "end": 2371,
                    "mention": "93",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 2372,
                    "end": 2374,
                    "mention": "94",
                    "ref_id": "BIBREF112"
                }
            ],
            "section": "Viral inhibitors and their mechanism of action ::: Current treatment scenario",
            "ref_spans": [
                {
                    "start": 2477,
                    "end": 2484,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "The virus life cycle begins when it infects a suitable host in order to make multiple copies of itself by utilizing the host machinery. The process from infection to generation of progeny virions is executed as a series of very well coordinated steps and involves attachment, entry, uncoating, replication-transcription-translation of genetic material, assembly and egress. The virus genome encodes a limited number of proteins, all of which can be categorized primarily into structural and non-structural proteins. While structural proteins generate the virus capsid, non-structural proteins are produced after infection and are usually not a part of the capsid.74,95 Recently, a set of viral proteins have been identified which play essential roles in the virus life cycle, primarily through their ability to interact with and penetrate cellular membranes. This class of multifunctional proteins, designated viroporins, form pores or channels in cellular membranes, which directly or indirectly facilitate the intracellular survival of the virus.96 It has been suggested that the ability of viroporins to alter ionic concentration and remodel host cell membranes, enhances viral uncoating, replication and egress.96 Usually viroporins are small peptides (up to 100 amino acids) and contain one or more transmembrane domain(s). Formation of pores or channels in cellular membranes is facilitated by homo-oligomerization between viroporins. Oligomerization levels can range from dimeric association (e.g. in HAV 2B)97 to large heptameric assemblies (e.g. in HCV p7).96 Till date, several viroporins have been identified and functionally characterized for both enveloped and non-enveloped viruses (Fig. 1, Table 2). Some of the well-known examples are influenza A virus M2, HIV-1 Vpu, picornavirus 2B and HCV p7.96",
            "cite_spans": [
                {
                    "start": 663,
                    "end": 665,
                    "mention": "74",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 666,
                    "end": 668,
                    "mention": "95",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 1048,
                    "end": 1050,
                    "mention": "96",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 1215,
                    "end": 1217,
                    "mention": "96",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 1515,
                    "end": 1517,
                    "mention": "97",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 1566,
                    "end": 1568,
                    "mention": "96",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 1811,
                    "end": 1813,
                    "mention": "96",
                    "ref_id": "BIBREF114"
                }
            ],
            "section": "Viroporins as promising inhibitor targets ::: Current treatment scenario",
            "ref_spans": [
                {
                    "start": 1697,
                    "end": 1703,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1705,
                    "end": 1712,
                    "mention": "Table 2",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "The central role of viroporins in facilitating several steps in the life cycle of viruses suggests that this class of viral proteins are promising candidates for development of inhibitor-based therapeutics. In fact, small molecule inhibitors have been successfully designed and tested against certain viroporins with encouraging outcomes; drugs such as amantadine and rimantadine have been shown to be effective in inhibiting the ion channel activity of M2.98,99 Interestingly, several influenza strains, with specific point mutations (Leu26Phe, Ser31Asn, Val27Ala, Ala30Thr, Leu28Phe Ser31Asn and Gly34Glu) which cause resistance to M2 inhibitors have been identified recently.79 These mutations most likely affect the drug binding sites of the M2 channel by altering binding pocket hydrophobicity or the overall conformation of the channel. The most prevalent point mutation is Ser31Asn, which has been identified in the H1N1, H7N9 and H1N5 strains of the virus. Attempts are currently being made to synthesize inhibitors against the resistant strains using derivatives of M2 inhibitors. Although novel effective derivatives have been obtained against several of the mutations, those against point mutations at Asn31 have proven to be difficult to generate.98",
            "cite_spans": [
                {
                    "start": 457,
                    "end": 459,
                    "mention": "98",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 460,
                    "end": 462,
                    "mention": "99",
                    "ref_id": "BIBREF117"
                },
                {
                    "start": 678,
                    "end": 680,
                    "mention": "79",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 1259,
                    "end": 1261,
                    "mention": "98",
                    "ref_id": "BIBREF116"
                }
            ],
            "section": "Viroporins as promising inhibitor targets ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Hexamethylene amilorides (HMA), and its derivatives (e.g. BIT225), have been found to be effective in blocking Vpu channel activity and is thought to bind in the channel lumen. The BIT225 HMA derivative is currently undergoing clinical trials.98 This inhibitor is specific to HIV-1 and till date no resistant strains have been reported.",
            "cite_spans": [
                {
                    "start": 243,
                    "end": 245,
                    "mention": "98",
                    "ref_id": "BIBREF116"
                }
            ],
            "section": "Viroporins as promising inhibitor targets ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Coronavirus-encoded E peptides are also effectively blocked by HMA, as has been observed in electrophysiology studies using HEK-293T cells.98 Amantadine is also capable of inhibiting activity, but the effect requires significantly higher concentrations.98",
            "cite_spans": [
                {
                    "start": 139,
                    "end": 141,
                    "mention": "98",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 253,
                    "end": 255,
                    "mention": "98",
                    "ref_id": "BIBREF116"
                }
            ],
            "section": "Viroporins as promising inhibitor targets ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Adamantanes, alkyl imino-sugars and HMA were identified as HCV p7 blockers based on protein based in vitro assays.98,100 However, studies reported inconsistency in efficacy data, which was preliminarily due to the genotypic/subtypic differences between the p7 channels, even though compounds like rimatadine and N-nonyl deoxynojirimycin (NN-DNJ) exhibited wide-spectrum activity amongst genotypes.98 Availability of high resolution structural data and in silico docking studies helped in unravelling the mechanism of action of these inhibitors.80 NN-DNJ was found to interfere with p7 oligomerization via interaction with a specific phenylalanine residue at the 25th position. Interestingly, the inhibitory activity of adamantane was found to be due to binding of the inhibitor at a peripheral site (Leu20) that is exposed on the membrane, separate from the NN-DNJ binding site.98 The disparate binding sites for inhibitors provides the possibility of using a combination therapy approach to treat resistant strains. Current drug development efforts typically use a combination of rational and high-throughput approaches. This has resulted in identification of compounds against resistant p7 phenotypes with higher potency at minimal concentrations.98",
            "cite_spans": [
                {
                    "start": 114,
                    "end": 116,
                    "mention": "98",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 117,
                    "end": 120,
                    "mention": "100",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 397,
                    "end": 399,
                    "mention": "98",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 544,
                    "end": 546,
                    "mention": "80",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 878,
                    "end": 880,
                    "mention": "98",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 1249,
                    "end": 1251,
                    "mention": "98",
                    "ref_id": "BIBREF116"
                }
            ],
            "section": "Viroporins as promising inhibitor targets ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Current interest and the pool of available data leads to the conclusion that viroporin-based therapeutic approaches will subsequently play an important role in treating clinically relevant human pathogens. The approaches towards designing inhibitors for treatment of HCV and its resistant phenotypes can also be extended to the other hepatotropic viruses. In fact, recent work from our laboratory has characterized the membrane activity of capsid component VP4 and non-structural protein 2B from HAV.97,101 Utilizing a combination of biophysical studies, MD simulation and electron microscopy, it was shown that VP4 forms discreet pores of 5\u223c9 nm in artificial membranes. Our data thus indicates that VP4 is a membrane penetrating peptide which may allow HAV to escape from endosomes and gain access to the cellular cytosol. The potentially critical role played by VP4 in HAV entry makes it an important target for design of inhibitors.",
            "cite_spans": [
                {
                    "start": 500,
                    "end": 502,
                    "mention": "97",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 503,
                    "end": 506,
                    "mention": "101",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Viroporins as promising inhibitor targets ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "We further investigated the non-structural 2B protein of HAV, which was found to contain a stretch of 60 residues in its C-terminus, and which has viroporin-like activity.97 A combination of crosslinking studies, biophysical assays and simulation was employed to determine that 2B probably forms dimers and generates \u223c3 nm pores in membranes. The resulting alteration of membrane permeability is thought to be essential for HAV replication. It is probable that inhibition of the membrane activity of 2B would negatively impact the viral replication process. Thus, a treatment regimen against HAV, which includes a combination therapy targeting VP4 and 2B, could be a very promising and effective approach.",
            "cite_spans": [
                {
                    "start": 171,
                    "end": 173,
                    "mention": "97",
                    "ref_id": "BIBREF115"
                }
            ],
            "section": "Viroporins as promising inhibitor targets ::: Current treatment scenario",
            "ref_spans": []
        },
        {
            "text": "Given the essential roles played by viroporins and viral membrane penetrating peptides in enhancing several aspects of the virus life cycle, targeted inhibitor therapy holds promise for development of virus-specific drugs. Establishing the commonalities between the structures and functions of these membrane active components might make it easier to design small molecule inhibitors. Finally, given the promise of p7-based therapy against HCV, it is essential to pinpoint such potential candidates in other hepatotropic viruses, in order to expand therapy options against chronic and acute viral hepatitis.",
            "cite_spans": [],
            "section": "Conclusion and future perspectives",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Fig. 1.: In the case of enveloped viruses, steps 1, 2, 3, 4 and 5 represent attachment, entry, uncoating and replication, assembly and egress, respectively. For non-enveloped viruses, steps 1, 2, 3, 4, 5 and 6 represent attachment, entry, release from the intracellular vesicle, uncoating and replication, assembly and egress processes.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Viral hepatitis: progress and promise",
            "authors": [
                {
                    "first": "NJ",
                    "middle": [],
                    "last": "Wood",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Nat Rev Gastroenterol Hepatol",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Escriou",
                    "suffix": ""
                },
                {
                    "first": "SF",
                    "middle": [],
                    "last": "Chao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Girard",
                    "suffix": ""
                },
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Lemon",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wychowski",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Virology",
            "volume": "213",
            "issn": "",
            "pages": "213-222",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Identification of Hydroxyanthraquinones as novel inhibitors of hepatitis C virus NS3 helicase",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Furuta",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tsubuki",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Endoh",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Miyamoto",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                },
                {
                    "first": "KA",
                    "middle": [],
                    "last": "Salam",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Int J Mol Sci",
            "volume": "16",
            "issn": "",
            "pages": "18439-18453",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "The VP4 peptide of hepatitis A virus ruptures membranes through formation of discrete pores",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shukla",
                    "suffix": ""
                },
                {
                    "first": "AK",
                    "middle": [],
                    "last": "Padhi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gomes",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Banerjee",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Virol",
            "volume": "88",
            "issn": "",
            "pages": "12409-12421",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Ethnopharmacol",
            "volume": "155",
            "issn": "",
            "pages": "1061-1067",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kanda",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nakamoto",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Saito",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nakamura",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Biochem Biophys Res Commun",
            "volume": "458",
            "issn": "",
            "pages": "908-912",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kanda",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sasaki",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nakamoto",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Haga",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nakamura",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shirasawa",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Biochem Biophys Res Commun",
            "volume": "466",
            "issn": "",
            "pages": "567-571",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Koh",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Canini",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Dahari",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "SL",
                    "middle": [],
                    "last": "Uprichard",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Haynes-Williams",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Lancet Infect Dis",
            "volume": "15",
            "issn": "",
            "pages": "1167-1174",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers",
            "authors": [
                {
                    "first": "JX",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sharpe",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ghirlando",
                    "suffix": ""
                },
                {
                    "first": "WM",
                    "middle": [],
                    "last": "Yau",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tycko",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Protein Sci",
            "volume": "19",
            "issn": "",
            "pages": "1877-1896",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "The elusive function of the hepatitis C virus p7 protein",
            "authors": [
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Atoom",
                    "suffix": ""
                },
                {
                    "first": "NG",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "RS",
                    "middle": [],
                    "last": "Russell",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Virology",
            "volume": "462\u2013463",
            "issn": "",
            "pages": "377-387",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "The M2 proton channels of influenza A and B viruses",
            "authors": [
                {
                    "first": "LH",
                    "middle": [],
                    "last": "Pinto",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Lamb",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Biol Chem",
            "volume": "281",
            "issn": "",
            "pages": "8997-9000",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "The coronavirus E protein: assembly and beyond",
            "authors": [
                {
                    "first": "TR",
                    "middle": [],
                    "last": "Ruch",
                    "suffix": ""
                },
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Machamer",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Viruses",
            "volume": "4",
            "issn": "",
            "pages": "363-382",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Hepatitis A virus: from discovery to vaccines",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Lemon",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "43",
            "issn": "",
            "pages": "S164-S172",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "BJ",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Schwarz",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "CK",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "103",
            "issn": "",
            "pages": "12540-12545",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Possible function for virus encoded K+ channel Kcv in the replication of chlorella virus PBCV-1",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mehmel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rothermel",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Meckel",
                    "suffix": ""
                },
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Van Etten",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Moroni",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Thiel",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "FEBS Lett",
            "volume": "552",
            "issn": "",
            "pages": "7-11",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "A very late viral protein triggers the lytic release of SV40",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Daniels",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sadowicz",
                    "suffix": ""
                },
                {
                    "first": "DN",
                    "middle": [],
                    "last": "Hebert",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "PLoS Pathog",
            "volume": "3",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release",
            "authors": [
                {
                    "first": "FJ",
                    "middle": [],
                    "last": "van Kuppeveld",
                    "suffix": ""
                },
                {
                    "first": "JG",
                    "middle": [],
                    "last": "Hoenderop",
                    "suffix": ""
                },
                {
                    "first": "RL",
                    "middle": [],
                    "last": "Smeets",
                    "suffix": ""
                },
                {
                    "first": "PH",
                    "middle": [],
                    "last": "Willems",
                    "suffix": ""
                },
                {
                    "first": "HB",
                    "middle": [],
                    "last": "Dijkman",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Galama",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "EMBO J",
            "volume": "16",
            "issn": "",
            "pages": "3519-3532",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Membrane integration of poliovirus 2B viroporin",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mart\u00ednez-Gil",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ba\u00f1\u00f3-Polo",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Redondo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "S\u00e1nchez-Mart\u00ednez",
                    "suffix": ""
                },
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Nieva",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Carrasco",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Virol",
            "volume": "85",
            "issn": "",
            "pages": "11315-11324",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Alphavirus 6K proteins form ion channels",
            "authors": [
                {
                    "first": "JV",
                    "middle": [],
                    "last": "Melton",
                    "suffix": ""
                },
                {
                    "first": "GD",
                    "middle": [],
                    "last": "Ewart",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Weir",
                    "suffix": ""
                },
                {
                    "first": "PG",
                    "middle": [],
                    "last": "Board",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "PW",
                    "middle": [],
                    "last": "Gage",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Biol Chem",
            "volume": "277",
            "issn": "",
            "pages": "46923-46931",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons",
            "authors": [
                {
                    "first": "SC",
                    "middle": [],
                    "last": "Piller",
                    "suffix": ""
                },
                {
                    "first": "GD",
                    "middle": [],
                    "last": "Ewart",
                    "suffix": ""
                },
                {
                    "first": "DA",
                    "middle": [],
                    "last": "Jans",
                    "suffix": ""
                },
                {
                    "first": "PW",
                    "middle": [],
                    "last": "Gage",
                    "suffix": ""
                },
                {
                    "first": "GB",
                    "middle": [],
                    "last": "Cox",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Virol",
            "volume": "73",
            "issn": "",
            "pages": "4230-4238",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "A proapoptotic peptide derived from reovirus outer capsid protein {micro}1 has membrane-destabilizing activity",
            "authors": [
                {
                    "first": "JW",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Lyi",
                    "suffix": ""
                },
                {
                    "first": "CR",
                    "middle": [],
                    "last": "Parrish",
                    "suffix": ""
                },
                {
                    "first": "JS",
                    "middle": [],
                    "last": "Parker",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Virol",
            "volume": "85",
            "issn": "",
            "pages": "1507-1516",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Infectious bursal disease virus, a non-enveloped virus, possesses a capsid-associated peptide that deforms and perforates biological membranes",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Galloux",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Libersou",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Morellet",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bouaziz",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Da Costa",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ouldali",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Biol Chem",
            "volume": "282",
            "issn": "",
            "pages": "20774-20784",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Hepatitis C virus entry into host cells",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Helle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Dubuisson",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Cell Mol Life Sci",
            "volume": "65",
            "issn": "",
            "pages": "100-112",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Hepatitis C virus entry: molecular biology and clinical implications",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Barth",
                    "suffix": ""
                },
                {
                    "first": "TJ",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "TF",
                    "middle": [],
                    "last": "Baumert",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hepatology",
            "volume": "44",
            "issn": "",
            "pages": "527-535",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "An overview of HCV molecular biology, replication and immune responses",
            "authors": [
                {
                    "first": "UA",
                    "middle": [],
                    "last": "Ashfaq",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Javed",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rehman",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Nawaz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Riazuddin",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Virol J",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "El-Hage",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Gen Virol",
            "volume": "84",
            "issn": "",
            "pages": "2761-2769",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gosert",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Egger",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Lohmann",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bartenschlager",
                    "suffix": ""
                },
                {
                    "first": "HE",
                    "middle": [],
                    "last": "Blum",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Bienz",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Virol",
            "volume": "77",
            "issn": "",
            "pages": "5487-5492",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kalia",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Chandra",
                    "suffix": ""
                },
                {
                    "first": "SA",
                    "middle": [],
                    "last": "Rahman",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sehgal",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jameel",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Virol",
            "volume": "83",
            "issn": "",
            "pages": "12714-12724",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "Heat shock cognate protein 70 may mediate the entry of hepatitis E virus into host cells",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "SU",
                    "middle": [],
                    "last": "Emerson",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Clin Virol",
            "volume": "36",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "Role of heat-shock protein 90 in hepatitis E virus capsid trafficking",
            "authors": [
                {
                    "first": "ZZ",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Miao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "AE",
                    "middle": [],
                    "last": "Yeo",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Gen Virol",
            "volume": "91",
            "issn": "",
            "pages": "1728-1736",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Systemic viral infections and collateral damage in the liver",
            "authors": [
                {
                    "first": "DH",
                    "middle": [],
                    "last": "Adams",
                    "suffix": ""
                },
                {
                    "first": "SG",
                    "middle": [],
                    "last": "Hubscher",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Am J Pathol",
            "volume": "168",
            "issn": "",
            "pages": "1057-1059",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Mol Model",
            "volume": "17",
            "issn": "",
            "pages": "987-995",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "Molecular biology and replication of hepatitis E virus",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "XJ",
                    "middle": [],
                    "last": "Meng",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Emerg Microbes Infect",
            "volume": "1",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Molecular virology of hepatitis E virus",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Ahmad",
                    "suffix": ""
                },
                {
                    "first": "RP",
                    "middle": [],
                    "last": "Holla",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jameel",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Virus Res",
            "volume": "161",
            "issn": "",
            "pages": "47-58",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Schulze",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gripon",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Urban",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Hepatology",
            "volume": "46",
            "issn": "",
            "pages": "1759-1768",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "The molecular virology of hepatitis B virus",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Glebe",
                    "suffix": ""
                },
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Bremer",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Semin Liver Dis",
            "volume": "33",
            "issn": "",
            "pages": "103-112",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Jing",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Elife",
            "volume": "1",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kann",
                    "suffix": ""
                },
                {
                    "first": "WH",
                    "middle": [],
                    "last": "Gerlich",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "J Virol",
            "volume": "68",
            "issn": "",
            "pages": "7993-8000",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wittkop",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Schwarz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cassany",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gr\u00fcn-Bernhard",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Delaleau",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rabe",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Cell Microbiol",
            "volume": "12",
            "issn": "",
            "pages": "962-975",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "Hepatitis B virus replication",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Beck",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nassal",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "World J Gastroenterol",
            "volume": "13",
            "issn": "",
            "pages": "48-64",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "Proteoglycans act as cellular hepatitis delta virus attachment receptors",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Lamas Longarela",
                    "suffix": ""
                },
                {
                    "first": "TT",
                    "middle": [],
                    "last": "Schmidt",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sch\u00f6neweis",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Romeo",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wedemeyer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Urban",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "PLoS One",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis\u2014United States, 2006",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Wasley",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Grytdal",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Gallagher",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "MMWR Surveill Summ",
            "volume": "57",
            "issn": "",
            "pages": "1-24",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "Life cycle and pathogenesis of hepatitis D virus: A review",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Abbas",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Afzal",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "World J Hepatol",
            "volume": "5",
            "issn": "",
            "pages": "666-675",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Werzberger",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Mensch",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Kuter",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lewis",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sitrin",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "N Engl J Med",
            "volume": "327",
            "issn": "",
            "pages": "453-457",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "Protection against hepatitis A by an inactivated vaccine",
            "authors": [
                {
                    "first": "BL",
                    "middle": [],
                    "last": "Innis",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Snitbhan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kunasol",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Laorakpongse",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Poopatanakool",
                    "suffix": ""
                },
                {
                    "first": "CA",
                    "middle": [],
                    "last": "Kozik",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "JAMA",
            "volume": "271",
            "issn": "",
            "pages": "1328-1334",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Midthun",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Ellerbeck",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Gershman",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Calandra",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Krah",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "McCaughtry",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "J Infect Dis",
            "volume": "163",
            "issn": "",
            "pages": "735-739",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance",
            "authors": [
                {
                    "first": "JT",
                    "middle": [],
                    "last": "Gerlach",
                    "suffix": ""
                },
                {
                    "first": "HM",
                    "middle": [],
                    "last": "Diepolder",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Zachoval",
                    "suffix": ""
                },
                {
                    "first": "NH",
                    "middle": [],
                    "last": "Gruener",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Jung",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ulsenheimer",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Gastroenterology",
            "volume": "125",
            "issn": "",
            "pages": "80-88",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF47": {
            "title": "EASL Clinical Practice Guidelines: management of hepatitis C virus infection",
            "authors": [],
            "year": 2011,
            "venue": "J Hepatol",
            "volume": "55",
            "issn": "",
            "pages": "245-264",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF48": {
            "title": "The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Antaki",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Craxi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kamal",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Moucari",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Van der Merwe",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Haffar",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Liver Int",
            "volume": "30",
            "issn": "",
            "pages": "342-355",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF49": {
            "title": "EASL recommendations on treatment of hepatitis C 2015.",
            "authors": [],
            "year": 2015,
            "venue": "J Hepatol",
            "volume": "63",
            "issn": "",
            "pages": "199-236",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF50": {
            "title": "Treatment of severe acute hepatitis E by ribavirin",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gerolami",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Borentain",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Raissouni",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Motte",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Solas",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Colson",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Clin Virol",
            "volume": "52",
            "issn": "",
            "pages": "60-62",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF51": {
            "title": "Pathogenesis and treatment of hepatitis e virus infection",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wedemeyer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pischke",
                    "suffix": ""
                },
                {
                    "first": "MP",
                    "middle": [],
                    "last": "Manns",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Gastroenterology",
            "volume": "142",
            "issn": "",
            "pages": "1388-1397",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF52": {
            "title": "Hepatocellular carcinoma review: current treatment, and evidence-based medicine",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Raza",
                    "suffix": ""
                },
                {
                    "first": "GK",
                    "middle": [],
                    "last": "Sood",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "World J Gastroenterol",
            "volume": "20",
            "issn": "",
            "pages": "4115-4127",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF53": {
            "title": "Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kamar",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Abravanel",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Selves",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Garrouste",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Esposito",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lavayssi\u00e8re",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Transplantation",
            "volume": "89",
            "issn": "",
            "pages": "353-360",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF54": {
            "title": "Brief communication: case reports of ribavirin treatment for chronic hepatitis E",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Mallet",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Nicand",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sultanik",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chakvetadze",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tess\u00e9",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Thervet",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Ann Intern Med",
            "volume": "153",
            "issn": "",
            "pages": "85-89",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF55": {
            "title": "Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kamar",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Rostaing",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Abravanel",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Garrouste",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lhomme",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Esposito",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Gastroenterology",
            "volume": "139",
            "issn": "",
            "pages": "1612-1618",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF56": {
            "title": "Maternal-fetal hepatitis E transmission: is it underestimated?",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "El Sayed Zaki",
                    "suffix": ""
                },
                {
                    "first": "MM",
                    "middle": [],
                    "last": "El Razek",
                    "suffix": ""
                },
                {
                    "first": "HM",
                    "middle": [],
                    "last": "El Razek",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Clin Transl Hepatol",
            "volume": "2",
            "issn": "",
            "pages": "117-123",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF57": {
            "title": "Vertical transmission of hepatitis E virus",
            "authors": [
                {
                    "first": "MS",
                    "middle": [],
                    "last": "Khuroo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kamili",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jameel",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Lancet",
            "volume": "345",
            "issn": "",
            "pages": "1025-1026",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF58": {
            "title": "Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Patra",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "SS",
                    "middle": [],
                    "last": "Trivedi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Puri",
                    "suffix": ""
                },
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Sarin",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Ann Intern Med",
            "volume": "147",
            "issn": "",
            "pages": "28-33",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF59": {
            "title": "Structure, regulation and function of NF-kappa B",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Siebenlist",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Franzoso",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Annu Rev Cell Biol",
            "volume": "10",
            "issn": "",
            "pages": "405-455",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF60": {
            "title": "Hepatitis B: the virus and disease",
            "authors": [
                {
                    "first": "TJ",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Hepatology",
            "volume": "49",
            "issn": "",
            "pages": "S13-S21",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF61": {
            "title": "Hepatitis B virus: from diagnosis to treatment",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "D\u00e9ny",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zoulim",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Pathol Biol (Paris)",
            "volume": "58",
            "issn": "",
            "pages": "245-253",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF62": {
            "title": "Management of acute hepatitis B",
            "authors": [
                {
                    "first": "ML",
                    "middle": [],
                    "last": "Shiffman",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Clin Liver Dis",
            "volume": "14",
            "issn": "",
            "pages": "75-91",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF63": {
            "title": "Human membrane protein Tim-3 facilitates hepatitis A virus entry into target cells",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Sui",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wan",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Int J Mol Med",
            "volume": "17",
            "issn": "",
            "pages": "1093-1099",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF64": {
            "title": "EASL clinical practice guidelines: Management of chronic hepatitis B virus infection",
            "authors": [],
            "year": 2012,
            "venue": "J Hepatol",
            "volume": "57",
            "issn": "",
            "pages": "167-185",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF65": {
            "title": "AASLD guidelines for treatment of chronic hepatitis B",
            "authors": [
                {
                    "first": "NA",
                    "middle": [],
                    "last": "Terrault",
                    "suffix": ""
                },
                {
                    "first": "NH",
                    "middle": [],
                    "last": "Bzowej",
                    "suffix": ""
                },
                {
                    "first": "KM",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Hwang",
                    "suffix": ""
                },
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Jonas",
                    "suffix": ""
                },
                {
                    "first": "MH",
                    "middle": [],
                    "last": "Murad",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Hepatology",
            "volume": "63",
            "issn": "",
            "pages": "261-283",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF66": {
            "title": "Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B",
            "authors": [
                {
                    "first": "GK",
                    "middle": [],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Piratvisuth",
                    "suffix": ""
                },
                {
                    "first": "KX",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Thongsawat",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cooksley",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "N Engl J Med",
            "volume": "352",
            "issn": "",
            "pages": "2682-2695",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF67": {
            "title": "Telbivudine (Ldt) Plus Peg-Interferon (Pegifn) in Hbeag-positive chronic hepatitis B - very potent antiviral efficacy but risk of peripheral neuropathy (Pn)",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Avila",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Wursthorn",
                    "suffix": ""
                },
                {
                    "first": "WL",
                    "middle": [],
                    "last": "Chuang",
                    "suffix": ""
                },
                {
                    "first": "GK",
                    "middle": [],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "CY",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Hepatol",
            "volume": "52",
            "issn": "",
            "pages": "S6-S7",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF68": {
            "title": "Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B",
            "authors": [
                {
                    "first": "JG",
                    "middle": [],
                    "last": "Reijnders",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Perquin",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "BE",
                    "middle": [],
                    "last": "Hansen",
                    "suffix": ""
                },
                {
                    "first": "HL",
                    "middle": [],
                    "last": "Janssen",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Gastroenterology",
            "volume": "139",
            "issn": "",
            "pages": "491-498",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF69": {
            "title": "Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B",
            "authors": [
                {
                    "first": "TT",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "CL",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kew Yoon",
                    "suffix": ""
                },
                {
                    "first": "SS",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "HS",
                    "middle": [],
                    "last": "Coelho",
                    "suffix": ""
                },
                {
                    "first": "FJ",
                    "middle": [],
                    "last": "Carrilho",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Hepatology",
            "volume": "51",
            "issn": "",
            "pages": "422-430",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF70": {
            "title": "Five years of treatment with tenofovir DF (TDF) for chronic hepatitis B (CHB) infection is associated with sustained viral suppression and significant regression of histological fibrosis and cirrhosis",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Buti",
                    "suffix": ""
                },
                {
                    "first": "EJ",
                    "middle": [],
                    "last": "Gane",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Krastev",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Flisiak",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Germanidis",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Hepatology",
            "volume": "54",
            "issn": "",
            "pages": "1011A-1012A",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF71": {
            "title": "Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B",
            "authors": [
                {
                    "first": "EJ",
                    "middle": [],
                    "last": "Heathcote",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marcellin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Buti",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Gane",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "De Man",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Krastev",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Gastroenterology",
            "volume": "140",
            "issn": "",
            "pages": "132-143",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF72": {
            "title": "A review of hepatitis B vaccination",
            "authors": [
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Geier",
                    "suffix": ""
                },
                {
                    "first": "DA",
                    "middle": [],
                    "last": "Geier",
                    "suffix": ""
                },
                {
                    "first": "AC",
                    "middle": [],
                    "last": "Zahalsky",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Expert Opin Drug Saf",
            "volume": "2",
            "issn": "",
            "pages": "113-122",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF73": {
            "title": "Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Schiff",
                    "suffix": ""
                },
                {
                    "first": "CL",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hadziyannis",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Neuhaus",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Terrault",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Colombo",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Liver Transpl",
            "volume": "13",
            "issn": "",
            "pages": "349-360",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF74": {
            "title": "Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles",
            "authors": [
                {
                    "first": "DA",
                    "middle": [],
                    "last": "Anderson",
                    "suffix": ""
                },
                {
                    "first": "BC",
                    "middle": [],
                    "last": "Ross",
                    "suffix": ""
                }
            ],
            "year": 1990,
            "venue": "J Virol",
            "volume": "64",
            "issn": "",
            "pages": "5284-5289",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF75": {
            "title": "Current management of hepatitis B virus infection before and after liver transplantation",
            "authors": [
                {
                    "first": "GV",
                    "middle": [],
                    "last": "Papatheodoridis",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Cholongitas",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Archimandritis",
                    "suffix": ""
                },
                {
                    "first": "AK",
                    "middle": [],
                    "last": "Burroughs",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Liver Int",
            "volume": "29",
            "issn": "",
            "pages": "1294-1305",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF76": {
            "title": "Treatment options for hepatitis delta virus infection",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Heidrich",
                    "suffix": ""
                },
                {
                    "first": "MP",
                    "middle": [],
                    "last": "Manns",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wedemeyer",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Curr Infect Dis Rep",
            "volume": "15",
            "issn": "",
            "pages": "31-38",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF77": {
            "title": "The future of antivirals: broad-spectrum inhibitors",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Debing",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Neyts",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Delang",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Curr Opin Infect Dis",
            "volume": "28",
            "issn": "",
            "pages": "596-602",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF78": {
            "title": "Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases",
            "authors": [
                {
                    "first": "LP",
                    "middle": [],
                    "last": "Jordheim",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Durantel",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zoulim",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Dumontet",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nat Rev Drug Discov",
            "volume": "12",
            "issn": "",
            "pages": "447-464",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF79": {
            "title": "Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Sluis-Cremer",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Tachedjian",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Virus Res",
            "volume": "134",
            "issn": "",
            "pages": "147-156",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF80": {
            "title": "New therapeutic strategies in HCV: polymerase inhibitors",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gerber",
                    "suffix": ""
                },
                {
                    "first": "TM",
                    "middle": [],
                    "last": "Welzel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zeuzem",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Liver Int",
            "volume": "33",
            "issn": "Suppl 1",
            "pages": "85-92",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF81": {
            "title": "HIV protease inhibitors: a review of molecular selectivity and toxicity",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Lv",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "HIV AIDS (Auckl)",
            "volume": "7",
            "issn": "",
            "pages": "95-104",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF82": {
            "title": "In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease",
            "authors": [
                {
                    "first": "AK",
                    "middle": [],
                    "last": "Patick",
                    "suffix": ""
                },
                {
                    "first": "SL",
                    "middle": [],
                    "last": "Binford",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Brothers",
                    "suffix": ""
                },
                {
                    "first": "RL",
                    "middle": [],
                    "last": "Jackson",
                    "suffix": ""
                },
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Ford",
                    "suffix": ""
                },
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Diem",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Antimicrob Agents Chemother",
            "volume": "43",
            "issn": "",
            "pages": "2444-2450",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF83": {
            "title": "Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts",
            "authors": [
                {
                    "first": "SF",
                    "middle": [],
                    "last": "G\u00f6thel",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Marahiel",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Cell Mol Life Sci",
            "volume": "55",
            "issn": "",
            "pages": "423-436",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF84": {
            "title": "Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kaul",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Stauffer",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Berger",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Pertel",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Schmitt",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kallis",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "PLoS Pathog",
            "volume": "5",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF85": {
            "title": "Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction",
            "authors": [
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Beard",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Lemon",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Virol",
            "volume": "75",
            "issn": "",
            "pages": "1414-1426",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF86": {
            "title": "DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Coelmont",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Hanoulle",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Chatterji",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Berger",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Snoeck",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bobardt",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "PLoS One",
            "volume": "5",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF87": {
            "title": "Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid",
            "authors": [
                {
                    "first": "TR",
                    "middle": [],
                    "last": "Gamble",
                    "suffix": ""
                },
                {
                    "first": "FF",
                    "middle": [],
                    "last": "Vajdos",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Yoo",
                    "suffix": ""
                },
                {
                    "first": "DK",
                    "middle": [],
                    "last": "Worthylake",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Houseweart",
                    "suffix": ""
                },
                {
                    "first": "WI",
                    "middle": [],
                    "last": "Sundquist",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Cell",
            "volume": "87",
            "issn": "",
            "pages": "1285-1294",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF88": {
            "title": "Lipid interactions during virus entry and infection",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mazzon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mercer",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Cell Microbiol",
            "volume": "16",
            "issn": "",
            "pages": "1493-1502",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF89": {
            "title": "Viral capsids and envelopes: Structure and function",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lucas",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "eLS",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF90": {
            "title": "Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Markowitz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zolopa",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Squires",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ruane",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Coakley",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Kearney",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Antimicrob Chemother",
            "volume": "69",
            "issn": "",
            "pages": "1362-1369",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF91": {
            "title": "Implications of efficient hepatic delivery by tenofovir alafenamide (GS-7340) for hepatitis B virus therapy",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Murakami",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hao",
                    "suffix": ""
                },
                {
                    "first": "EI",
                    "middle": [],
                    "last": "Lepist",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Babusis",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Antimicrob Agents Chemother",
            "volume": "59",
            "issn": "",
            "pages": "3563-3569",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF92": {
            "title": "A phase 3 study of tenofovir alafenamide compared with tenofovir disoproxil fumarate in patients with HBeAg-positive, chronic hepatitis B: week 48 efficacy and safety results",
            "authors": [
                {
                    "first": "HLY",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fung",
                    "suffix": ""
                },
                {
                    "first": "WK",
                    "middle": [],
                    "last": "Seto",
                    "suffix": ""
                },
                {
                    "first": "WL",
                    "middle": [],
                    "last": "Chuang",
                    "suffix": ""
                },
                {
                    "first": "CY",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "HJ",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Hepatol",
            "volume": "64",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF93": {
            "title": "A phase 3 study of tenofovir alafenamide compared with tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: week 48 efficacy and safety results",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Buti",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Gane",
                    "suffix": ""
                },
                {
                    "first": "WK",
                    "middle": [],
                    "last": "Seto",
                    "suffix": ""
                },
                {
                    "first": "HLY",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "WL",
                    "middle": [],
                    "last": "Chuang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Stepanova",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Hepatol",
            "volume": "64",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF94": {
            "title": "Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B",
            "authors": [
                {
                    "first": "CL",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Ahn",
                    "suffix": ""
                },
                {
                    "first": "KS",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Um",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Yoon",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Gut",
            "volume": "63",
            "issn": "",
            "pages": "996-1004",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF95": {
            "title": "Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: results from a multicentre study",
            "authors": [
                {
                    "first": "MF",
                    "middle": [],
                    "last": "Yuen",
                    "suffix": ""
                },
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Ahn",
                    "suffix": ""
                },
                {
                    "first": "KS",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Um",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cho",
                    "suffix": ""
                },
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Yoon",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Hepatol",
            "volume": "62",
            "issn": "",
            "pages": "526-532",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF96": {
            "title": "Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "B\u00e9nichou",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Virol",
            "volume": "76",
            "issn": "",
            "pages": "7495-7505",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF97": {
            "title": "The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Volz",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Allweiss",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ben MBarek",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Warlich",
                    "suffix": ""
                },
                {
                    "first": "AW",
                    "middle": [],
                    "last": "Lohse",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Pollok",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Hepatol",
            "volume": "58",
            "issn": "",
            "pages": "861-867",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF98": {
            "title": "Progress and prospects of anti-HBV gene therapy development",
            "authors": [
                {
                    "first": "MB",
                    "middle": [],
                    "last": "Maepa",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Roelofse",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ely",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Arbuthnot",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Int J Mol Sci",
            "volume": "16",
            "issn": "",
            "pages": "17589-17610",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF99": {
            "title": "Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs",
            "authors": [
                {
                    "first": "TJ",
                    "middle": [],
                    "last": "Cradick",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Keck",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bradshaw",
                    "suffix": ""
                },
                {
                    "first": "AC",
                    "middle": [],
                    "last": "Jamieson",
                    "suffix": ""
                },
                {
                    "first": "AP",
                    "middle": [],
                    "last": "McCaffrey",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Mol Ther",
            "volume": "18",
            "issn": "",
            "pages": "947-954",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF100": {
            "title": "An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Mol Ther",
            "volume": "22",
            "issn": "",
            "pages": "303-311",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF101": {
            "title": "Evolution and classification of the CRISPR-Cas systems",
            "authors": [
                {
                    "first": "KS",
                    "middle": [],
                    "last": "Makarova",
                    "suffix": ""
                },
                {
                    "first": "DH",
                    "middle": [],
                    "last": "Haft",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Barrangou",
                    "suffix": ""
                },
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Brouns",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Charpentier",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Horvath",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Nat Rev Microbiol",
            "volume": "9",
            "issn": "",
            "pages": "467-477",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF102": {
            "title": "The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo",
            "authors": [
                {
                    "first": "SR",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "HC",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "YT",
                    "middle": [],
                    "last": "Kuo",
                    "suffix": ""
                },
                {
                    "first": "CJ",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "TY",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "KC",
                    "middle": [],
                    "last": "Sung",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Mol Ther Nucleic Acids",
            "volume": "3",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF103": {
            "title": "Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mills",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Aldrich",
                    "suffix": ""
                },
                {
                    "first": "JR",
                    "middle": [],
                    "last": "Saputelli",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Antimicrob Agents Chemother",
            "volume": "56",
            "issn": "",
            "pages": "4277-4288",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF104": {
            "title": "Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators",
            "authors": [
                {
                    "first": "SP",
                    "middle": [],
                    "last": "Katen",
                    "suffix": ""
                },
                {
                    "first": "SR",
                    "middle": [],
                    "last": "Chirapu",
                    "suffix": ""
                },
                {
                    "first": "MG",
                    "middle": [],
                    "last": "Finn",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zlotnick",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "ACS Chem Biol",
            "volume": "5",
            "issn": "",
            "pages": "1125-1136",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF105": {
            "title": "Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Naduthambi",
                    "suffix": ""
                },
                {
                    "first": "RT",
                    "middle": [],
                    "last": "Mosley",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Niu",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Furman",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Otto",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Bioorg Med Chem Lett",
            "volume": "21",
            "issn": "",
            "pages": "4642-4647",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF106": {
            "title": "Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids",
            "authors": [
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Campagna",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mao",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mills",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cai",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Virol",
            "volume": "87",
            "issn": "",
            "pages": "6931-6942",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF107": {
            "title": "Maturation of the hepatitis A virus capsid protein VP1 is not dependent on processing by the 3Cpro proteinase",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "B\u00e9nichou",
                    "suffix": ""
                },
                {
                    "first": "SF",
                    "middle": [],
                    "last": "Chao",
                    "suffix": ""
                },
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Lemon",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Virol",
            "volume": "73",
            "issn": "",
            "pages": "6220-6227",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF108": {
            "title": "Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection",
            "authors": [
                {
                    "first": "CI",
                    "middle": [],
                    "last": "Wooddell",
                    "suffix": ""
                },
                {
                    "first": "DB",
                    "middle": [],
                    "last": "Rozema",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hossbach",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "John",
                    "suffix": ""
                },
                {
                    "first": "HL",
                    "middle": [],
                    "last": "Hamilton",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Mol Ther",
            "volume": "21",
            "issn": "",
            "pages": "973-985",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF109": {
            "title": "Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent",
            "authors": [
                {
                    "first": "RG",
                    "middle": [],
                    "last": "Gish",
                    "suffix": ""
                },
                {
                    "first": "MF",
                    "middle": [],
                    "last": "Yuen",
                    "suffix": ""
                },
                {
                    "first": "HL",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "BD",
                    "middle": [],
                    "last": "Given",
                    "suffix": ""
                },
                {
                    "first": "CL",
                    "middle": [],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "SA",
                    "middle": [],
                    "last": "Locarnini",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Antiviral Res",
            "volume": "121",
            "issn": "",
            "pages": "97-108",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF110": {
            "title": "Therapeutic antiviral effect of the nucleic acid polymer REP 2055 against persistent duck hepatitis B virus infection",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Noordeen",
                    "suffix": ""
                },
                {
                    "first": "CA",
                    "middle": [],
                    "last": "Scougall",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Grosse",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Qiao",
                    "suffix": ""
                },
                {
                    "first": "BB",
                    "middle": [],
                    "last": "Ajilian",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Reaiche-Miller",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "PLoS One",
            "volume": "10",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF111": {
            "title": "Beta-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "Tavis",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Antiviral Res",
            "volume": "99",
            "issn": "",
            "pages": "221-229",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF112": {
            "title": "Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lomonosova",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "EA",
                    "middle": [],
                    "last": "Moran",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Meyers",
                    "suffix": ""
                },
                {
                    "first": "SF",
                    "middle": [],
                    "last": "Le Grice",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Antimicrob Agents Chemother",
            "volume": "59",
            "issn": "",
            "pages": "1070-1079",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF113": {
            "title": "Homologous sequences in non-structural proteins from cowpea mosaic virus and picornaviruses",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Franssen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Leunissen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Goldbach",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lomonossoff",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zimmern",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "EMBO J",
            "volume": "3",
            "issn": "",
            "pages": "855-861",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF114": {
            "title": "Viroporins",
            "authors": [
                {
                    "first": "ME",
                    "middle": [],
                    "last": "Gonzalez",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Carrasco",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "FEBS Lett",
            "volume": "552",
            "issn": "",
            "pages": "28-34",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF115": {
            "title": "The C-terminal region of the non-structural protein 2B from Hepatitis A Virus demonstrates lipid-specific viroporin-like activity",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shukla",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Dey",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Banerjee",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nain",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Banerjee",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Sci Rep",
            "volume": "5",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF116": {
            "title": "Viroporins: structure, function and potential as antiviral targets",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Scott",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Griffin",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Gen Virol",
            "volume": "96",
            "issn": "",
            "pages": "2000-2027",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF117": {
            "title": "The minimalist architectures of viroporins and their therapeutic implications",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "OuYang",
                    "suffix": ""
                },
                {
                    "first": "JJ",
                    "middle": [],
                    "last": "Chou",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Biochim Biophys Acta",
            "volume": "1838",
            "issn": "",
            "pages": "1058-1067",
            "other_ids": {
                "DOI": []
            }
        }
    }
}